The NSW government will spend $16m for a free vaccination scheme to combat respiratory syncytial virus in babies, starting ...

A virus which hospitalises children across the country is being tackled with a $16m injection from one state government.

Coughing, sneezing, and high temperature are common signs of a cold. While these may look harmless, they can also be symptoms ...

The other group at the highest risk when it comes to RSV is children under age five, and specifically infants—especially ...

Respiratory syncytial virus (RSV) is the most important cause of infantile bronchiolitis and pneumonia. It is ubiquitous, with most children acquiring their primary infection within the first year ...

Current guidelines recommend that pregnant people receive a vaccine against respiratory syncytial virus (RSV) -- which typically causes mild, cold-like symptoms in most adults but can be deadly for ...

Johnson East took Bear in for his shot during his first pediatrician appointment. “He handled it very well,” she remembers. “We didn’t see any side effects with him. We were walked through the side ...

Regarding hospitalizations among immunocompetent older adults, vaccine effectiveness was 83% for the GSK vaccine and 73% for ...

Public health officials reiterated the importance of vaccines after seeing a rise in circulating levels of respiratory syncytial virus (RSV).

The respiratory virus is the leading cause of hospitalisation for infants, with 12,000 babies admitted each year. Before next ...

A Winnipeg mother with a newborn is pleading with the province to start offering RSV shots to all babies. As we navigate ...

For adults aged 60 years or older, RSV vaccination is effective for preventing associated hospitalizations and ED encounters.